MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia

References

• Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051–1062.
   PubMed Web of Science ®Google Scholar
• Garzon R, Heaphy CE, Havelange V, et al. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009;114:5331–5341.
   PubMed Web of Science ®Google Scholar
• Liu CX, Zhou HC, Yin QQ, et al. Targeting peroxiredoxins against leukemia. Exp Cell Res 2013;319:170–176.
   PubMed Web of Science ®Google Scholar
• Mrozek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007;109:431–448.
   PubMed Web of Science ®Google Scholar
• Croce CM. MicroRNA dysregulation in acute myeloid leukemia. J Clin Oncol 2013;31:2065–2066.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Mrozek K, Radmacher MD, et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 2011;117:1121–1129.
   PubMed Web of Science ®Google Scholar
• Erdogan B, Bosompem A, Peng D, et al. Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes. Leuk Lymphoma 2013;54:2720–2727.
   PubMed Web of Science ®Google Scholar
• Wu L, Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 2008;29:1–7.
   PubMedGoogle Scholar
• Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008;15:352–358.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857–866.
   PubMed Web of Science ®Google Scholar
• Jongen-Lavrencic M, Sun SM, Dijkstra MK, et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008;111:5078–5085.
   PubMed Web of Science ®Google Scholar
• Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008;111:3183–3189.
   PubMed Web of Science ®Google Scholar
• Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008;105:15535–15540.
   PubMed Web of Science ®Google Scholar
• Dixon-McIver A, East P, Mein CA, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008;3:e2141.
   PubMed Web of Science ®Google Scholar
• Popovic R, Riesbeck LE, Velu CS, et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009;113:3314–3322.
   PubMed Web of Science ®Google Scholar
• Gao SM, Yang J, Chen C, et al. miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. Leuk Lymphoma 2011;52:2365–2371.
   PubMed Web of Science ®Google Scholar
• Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007;12:457–466.
   PubMed Web of Science ®Google Scholar
• Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008;451:1125–1129.
   PubMed Web of Science ®Google Scholar
• Mott JL, Kobayashi S, Bronk SF, et al. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007;26:6133–6140.
   PubMed Web of Science ®Google Scholar
• Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009;113:6411–6418.
   PubMed Web of Science ®Google Scholar
• Pulikkan JA, Dengler V, Peramangalam PS, et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010;115: 1768–1778.
   PubMed Web of Science ®Google Scholar
• Liu S, Wu LC, Pang J, et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010;17:333–347.
   PubMed Web of Science ®Google Scholar
• Chang TS, Cho CS, Park S, et al. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 2004;279:41975–41984.
   PubMed Web of Science ®Google Scholar
• Wood ZA, Schroder E, Robin Harris J, et al. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003; 28:32–40.
   PubMed Web of Science ®Google Scholar
• Li X, Lu D, He F, et al. Cullin 4B protein ubiquitin ligase targets peroxiredoxin III for degradation. J Biol Chem 2011;286:32344–32354.
   PubMed Web of Science ®Google Scholar
• Monteiro G, Horta BB, Pimenta DC, et al. Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C. Proc Natl Acad Sci USA 2007;104:4886–4891.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005;38:1543–1552.
   PubMed Web of Science ®Google Scholar
• Lehtonen ST, Markkanen PM, Peltoniemi M, et al. Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress. Am J Physiol Lung Cell Mol Physiol 2005;288:L997–L1001.
   PubMed Web of Science ®Google Scholar
• Kang SW, Rhee SG, Chang TS, et al. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med 2005;11:571–578.
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim TN, Kim S, et al. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 2002;22:3331–3335.
   PubMed Web of Science ®Google Scholar
• Salvatori B, Iosue I, Mangiavacchi A, et al. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis 2012; 3:e413.
   PubMed Web of Science ®Google Scholar
• Betel D, Wilson M, Gabow A, et al. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008;36:D149–D153.
   PubMed Web of Science ®Google Scholar
• Wang X, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008; 24:325–332.
   PubMed Web of Science ®Google Scholar
• Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495–500.
   PubMed Web of Science ®Google Scholar
• Tothova Z, Gilliland DG. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 2007;1:140–152.
   PubMed Web of Science ®Google Scholar
• Owusu-Ansah E, Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009;461:537–541.
   PubMed Web of Science ®Google Scholar
• Sutherland JA, Turner AR, Mannoni P, et al. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J Biol Response Mod 1986;5:250–262.
   PubMedGoogle Scholar
• Ojima Y, Duncan MT, Nurhayati RW, et al. Synergistic effect of hydrogen peroxide on polyploidization during the megakaryocytic differentiation of K562 leukemia cells by PMA. Exp Cell Res 2013; 319:2205–2215.
   PubMed Web of Science ®Google Scholar
• Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008;105:3945–3950.
   PubMed Web of Science ®Google Scholar
• Gao J, Liu QG. The role of miR-26 in tumors and normal tissues (Review). Oncol Lett 2011;2:1019–1023.
   PubMed Web of Science ®Google Scholar
• Maillot G, Lacroix-Triki M, Pierredon S, et al. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res 2009;69:8332–8340.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang H, He H, et al. Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol 2004; 42:95–102.
   Web of Science ®Google Scholar
• Zaman MS, Thamminana S, Shahryari V, et al. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One 2012;7:e50203.
   PubMed Web of Science ®Google Scholar
• Wu Q, Wang C, Lu Z, et al. Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 2012;413: 1058–1065.
   PubMed Web of Science ®Google Scholar
• Baier M, Dietz KJ. The plant 2-Cys peroxiredoxin BAS1 is a nuclear-encoded chloroplast protein: its expressional regulation, phylogenetic origin, and implications for its specific physiological function in plants. Plant J 1997;12:179–190.
   PubMed Web of Science ®Google Scholar
• Muller FL, Lustgarten MS, Jang Y, et al. Trends in oxidative aging theories. Free Radic Biol Med 2007;43:477–503.
   PubMed Web of Science ®Google Scholar
• Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007;110:3056–3063.
   PubMed Web of Science ®Google Scholar
• Callens C, Coulon S, Naudin J, et al. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med 2010;207:731–750.
   PubMed Web of Science ®Google Scholar
• Lopez-Pedrera C, Villalba JM, Siendones E, et al. Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets. Proteomics 2006;6(Suppl. 1):S293–S299.
   PubMedGoogle Scholar
• Agrawal-Singh S, Isken F, Agelopoulos K, et al. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood 2012;119:2346–2357.
   PubMed Web of Science ®Google Scholar